U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Safety device for a blood treatment machine and a method of increasing the safety of a blood treatment machine

Patent 6767333 Issued on July 27, 2004. Estimated Expiration Date: Icon_subject August 28, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Ultrafiltration control system
Patent #: 4202764
Issued on: 05/13/1980
Inventor: Afflerbaugh ,   et al.

Automatic ultrafiltration control system
Patent #: 4381999
Issued on: 05/03/1983
Inventor: Boucher ,   et al.

Apparatus and method for plasma separation
Patent #: 4936980
Issued on: 06/26/1990
Inventor:

Artificial kidney with device for filtering dialysis liquid
Patent #: 5431811
Issued on: 07/11/1995
Inventor: Tusini, et al.

Liquid filtering and supply system controlling recirculation responsive to pressure difference across filter
Patent #: 5589077
Issued on: 12/31/1996
Inventor: Matsuda, et al.

Hemo(dia)filtration apparatus and filtrate flow regulator Patent #: 5660722
Issued on: 08/26/1997
Inventor: Nederlof

Inventors

Assignee

Application

No. 09649213 filed on 08/28/2000

US Classes:

604/6.09, Filter means604/4.01, BLOOD DRAWN AND REPLACED OR TREATED AND RETURNED TO BODY604/6.11, Pumping means210/646Hemodialysis

Examiners

Primary: Sykes, Angela D.
Assistant: Deak, Leslie R.

Attorney, Agent or Firm

Foreign Patent References

  • 34 16 057 DE 10/01/1985
  • 42 39 937 DE 06/01/1994

International Classes

A61M 3700
C02F 144

Abstract

A device and method for increasing the safety of an extracorporeal blood treatment machine are based on monitoring transmembrane pressure. The transmembrane pressure measured by a measuring device during the treatment is compared with an upper limit transmembrane pressure L1 and a lower limit transmembrane pressure L2 which define a monitoring window. If the transmembrane pressure is outside this monitoring window, an alarm is triggered by an alarm device. The monitoring window is shifted as a function of the ultrafiltration rate. To determine the window limits, the transmembrane pressure is established after a change in the ultrafiltration rate is calculated. Thereafter, the window limits are determined on the basis of the expected transmembrane pressure.

Other References

  • F. von der Haar et al., “Microprocessor-controlled, volumetric ultrafiltration with a hemodialysis unit,” Biomed. Technik, 29 (1984), pp. 141-146.
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?